[go: up one dir, main page]

HK1125931B - 趨化因子受體活性的調質、晶型以及製備方法 - Google Patents

趨化因子受體活性的調質、晶型以及製備方法 Download PDF

Info

Publication number
HK1125931B
HK1125931B HK09104387.4A HK09104387A HK1125931B HK 1125931 B HK1125931 B HK 1125931B HK 09104387 A HK09104387 A HK 09104387A HK 1125931 B HK1125931 B HK 1125931B
Authority
HK
Hong Kong
Prior art keywords
mcp
compound
disease
ccr2
oxo
Prior art date
Application number
HK09104387.4A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1125931A1 (zh
Inventor
Michael G. Yang
Robert J. Cherney
Martin G. Eastgate
Jale Muslehiddinoglu
Siva Josyula Prasad
Zili Xiao
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/782,704 external-priority patent/US7671062B2/en
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of HK1125931A1 publication Critical patent/HK1125931A1/zh
Publication of HK1125931B publication Critical patent/HK1125931B/zh

Links

HK09104387.4A 2006-07-28 2007-07-26 趨化因子受體活性的調質、晶型以及製備方法 HK1125931B (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US83423506P 2006-07-28 2006-07-28
US60/834,235 2006-07-28
US89602607P 2007-03-21 2007-03-21
US60/896,026 2007-03-21
US11/782,704 2007-07-25
US11/782,704 US7671062B2 (en) 2006-07-28 2007-07-25 Modulators of chemokine receptor activity, crystalline forms and process
PCT/US2007/074438 WO2008014381A2 (en) 2006-07-28 2007-07-26 Modulators of chemokine receptor activity, crystalline forms and process

Publications (2)

Publication Number Publication Date
HK1125931A1 HK1125931A1 (zh) 2009-08-21
HK1125931B true HK1125931B (zh) 2011-03-25

Family

ID=

Similar Documents

Publication Publication Date Title
EP2049477B1 (en) Modulators of chemokine receptor activity, crystalline forms and process
US8906920B2 (en) N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
EP2049519B1 (en) Cyclic derivatives as modulators of chemokine receptor activity
US8049019B2 (en) Substituted pyrrolidine-2-one compounds
HK1125931B (zh) 趨化因子受體活性的調質、晶型以及製備方法
HK1130476B (zh) 趨化因子受體活性的調質、晶形和方法
HK1188986A (zh) N-((1r，2s，5r)-5-(第三-丁基胺基)-2-((s)-3-(7-第三-丁基吡唑並[1，5-a][1，3，5]三-4-基胺基)-2-氧代吡咯烷-1-基)環己基)乙醯胺，趨化激素受體活性之雙重調節劑，晶形及方法